Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

May 08, 2001; 56 (9) Clinical/Scientific Notes

Association between the α1a calcium channel gene CACNA1A and idiopathic generalized epilepsy

B. Chioza, H. Wilkie, L. Nashef, J. Blower, D. McCormick, P. Sham, P. Asherson, A.J. Makoff
First published May 8, 2001, DOI: https://doi.org/10.1212/WNL.56.9.1245
B. Chioza
From the Department of Psychological Medicine (B. Chioza, H. Wilkie, Drs. Sham and Makoff) and the Social Genetic and Developmental Psychiatry Research Centre (Drs. Sham and Asherson), Institute of Psychiatry, London; the Department of Neurology (Drs. Nashef and Blower) and the Paediatric Department (Dr. McCormick), Kent and Canterbury Hospital, Canterbury; and Department of Neurology (Dr. Nashef), Kings’ College Hospital, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Wilkie
From the Department of Psychological Medicine (B. Chioza, H. Wilkie, Drs. Sham and Makoff) and the Social Genetic and Developmental Psychiatry Research Centre (Drs. Sham and Asherson), Institute of Psychiatry, London; the Department of Neurology (Drs. Nashef and Blower) and the Paediatric Department (Dr. McCormick), Kent and Canterbury Hospital, Canterbury; and Department of Neurology (Dr. Nashef), Kings’ College Hospital, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Nashef
From the Department of Psychological Medicine (B. Chioza, H. Wilkie, Drs. Sham and Makoff) and the Social Genetic and Developmental Psychiatry Research Centre (Drs. Sham and Asherson), Institute of Psychiatry, London; the Department of Neurology (Drs. Nashef and Blower) and the Paediatric Department (Dr. McCormick), Kent and Canterbury Hospital, Canterbury; and Department of Neurology (Dr. Nashef), Kings’ College Hospital, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Blower
From the Department of Psychological Medicine (B. Chioza, H. Wilkie, Drs. Sham and Makoff) and the Social Genetic and Developmental Psychiatry Research Centre (Drs. Sham and Asherson), Institute of Psychiatry, London; the Department of Neurology (Drs. Nashef and Blower) and the Paediatric Department (Dr. McCormick), Kent and Canterbury Hospital, Canterbury; and Department of Neurology (Dr. Nashef), Kings’ College Hospital, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. McCormick
From the Department of Psychological Medicine (B. Chioza, H. Wilkie, Drs. Sham and Makoff) and the Social Genetic and Developmental Psychiatry Research Centre (Drs. Sham and Asherson), Institute of Psychiatry, London; the Department of Neurology (Drs. Nashef and Blower) and the Paediatric Department (Dr. McCormick), Kent and Canterbury Hospital, Canterbury; and Department of Neurology (Dr. Nashef), Kings’ College Hospital, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Sham
From the Department of Psychological Medicine (B. Chioza, H. Wilkie, Drs. Sham and Makoff) and the Social Genetic and Developmental Psychiatry Research Centre (Drs. Sham and Asherson), Institute of Psychiatry, London; the Department of Neurology (Drs. Nashef and Blower) and the Paediatric Department (Dr. McCormick), Kent and Canterbury Hospital, Canterbury; and Department of Neurology (Dr. Nashef), Kings’ College Hospital, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Asherson
From the Department of Psychological Medicine (B. Chioza, H. Wilkie, Drs. Sham and Makoff) and the Social Genetic and Developmental Psychiatry Research Centre (Drs. Sham and Asherson), Institute of Psychiatry, London; the Department of Neurology (Drs. Nashef and Blower) and the Paediatric Department (Dr. McCormick), Kent and Canterbury Hospital, Canterbury; and Department of Neurology (Dr. Nashef), Kings’ College Hospital, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.J. Makoff
From the Department of Psychological Medicine (B. Chioza, H. Wilkie, Drs. Sham and Makoff) and the Social Genetic and Developmental Psychiatry Research Centre (Drs. Sham and Asherson), Institute of Psychiatry, London; the Department of Neurology (Drs. Nashef and Blower) and the Paediatric Department (Dr. McCormick), Kent and Canterbury Hospital, Canterbury; and Department of Neurology (Dr. Nashef), Kings’ College Hospital, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Association between the α1a calcium channel gene CACNA1A and idiopathic generalized epilepsy
B. Chioza, H. Wilkie, L. Nashef, J. Blower, D. McCormick, P. Sham, P. Asherson, A.J. Makoff
Neurology May 2001, 56 (9) 1245-1246; DOI: 10.1212/WNL.56.9.1245

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
482

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Idiopathic generalized epilepsy (IGE) is a common disorder with a strong genetic component. For common forms of IGE, the pattern of inheritance is complex, probably resulting from the action of a few or many genes of small to moderate effect. In this study we used an association strategy to investigate whether genetic variation of the α1A subunit of the voltage-gated calcium channel gene (CACNA1A) influences risk for IGE. The α1A subunit is the pore-forming channel in P/Q-type channels that plays an important role in neurotransmitter release.1 Mutations in the mouse homologue cause seizures and ataxia in tottering and leaner mice.2 In humans, mutations in CACNA1A result in episodic ataxia type 2, spinocerebellar ataxia type 6, and familial hemiplegic migraine.3 In an earlier study of only 55 probands, no association was reported between a CAG repeat polymorphism in exon 47 and the common subtypes of IGE.4

Although IGE includes many syndromes, their phenotypes overlap and more than one subtype is often observed within families, suggesting genes common to more than one subtype. We collected DNA from a cohort of Caucasian patients with IGE, unselected for subtype, at Kent and Canterbury Hospital. All probands had generalized spike and wave on EEG, normal background rhythm, and a clinical history consistent with IGE. Control subjects consisted of patients at the same hospital and the same ethnic group with no history of epilepsy or blackouts. We also collected DNA from both parents, when available, for within-family tests of association.

Results of this study are shown in the table. We analyzed four single nucleotide polymorphisms (SNP) in exons 6, 8, 16, and 20 (SNP6, -8, -16 and -20) and one simple sequence repeat polymorphism in intron 8 (D19S1150). Of these, SNP8 (OR, 1.8; 95% CI, 1.3 to 2.4; p = 0.00033) and D19S1150 (p = 0.032) showed evidence of allelic association. When corrected for multiple testing the association of SNP8 was still significant (Bonferroni-adjusted p = 0.0016). The D19S1150 association derives mainly from an excess of allele 6 in the probands compared with the control subjects (16.9% versus 9.6%, χ2 = 8.28; df = 1; p = 0.004; OR, 1.9; 95% CI, 1.2 to 3.0). All genotype frequencies were within Hardy–Weinberg equilibrium. Power calculations showed that the sample size had 80% power at p = 0.05 to detect associations with SNP6 at an OR of 4.2, with SNP16 at an OR of 1.9, and with SNP20 at an OR of 2.1. Although SNP6 is too infrequent to be informative with our sample size, smaller gene effects would be detected in SNP16 and SNP20, but not as small as the gene effect associated with SNP8.

View this table:
  • View inline
  • View popup
Table 1.

Allele frequencies of CACNA1A polymorphisms

For the two associated markers, we controlled for the possible effects of population stratification by performing within-family analyses in the subset of probands with parental DNA. For SNP8, haplotype-based relative risk analysis demonstrated a significant difference between transmitted and untransmitted alleles (p = 0.044). Moreover, there was no difference between untransmitted and control allele frequencies (36.1% versus 36.8%) suggesting similar genetic background between patients and control subjects (see table). The transmission disequilibrium test showed that of 65 informative transmissions, 42 A-alleles were transmitted versus 23 untransmitted (p = 0.019; OR, 1.8). For D19S1150, neither haplotype relative risk nor transmission disequilibrium test analyses yielded significant results, although similar control and untransmitted allele frequencies again suggest matching genetic backgrounds between patients and control subjects. Because of lower sample size, the within-family studies had much less power than the case-control studies.

These results provide the first direct evidence that CACNA1A is involved in the etiology of IGE. SNP8 is a silent polymorphism and is unlikely to have a functional effect itself. The association with IGE is therefore likely to result from linkage disequilibrium between SNP8 and a nearby functional polymorphism. For most outbred populations, linkage disequilibrium between SNP is estimated to extend between 3 and 50 kb5,6⇓ and up to 1000 kb for simple sequence repeat polymorphisms.7 CACNA1A has not been completely sequenced, but the size of genomic region spanning the coding region has been estimated at 300 kb.3 Thus, the putative IGE susceptibility locus is likely to lie within 50 kb of exon 8. The CAG repeat polymorphism at the 3′ end of the gene that failed to show association4 is well outside this range.

Further work is now required to delineate the region most likely to contain the functional variant giving rise to this association. We are presently screening CACNA1A for mutations around SNP8 to define the region of interest more precisely. We are also engaged in detailed clinical characterization of patients in our IGE sample, which will enable us to ascertain whether these results are due to a small gene effect throughout the sample or a larger gene effect in a subset.

Acknowledgments

Supported in part by the Epilepsy Research Foundation. B.C. is supported by a grant from the King’s Joint Research Committee, H.W. by an MRC studentship, and J.B. by the Epilepsy Research Foundation.

  • Received August 28, 2000.
  • Accepted in final form January 16, 2001.

References

  1. ↵
    Dunlap K, Luebke JI, Turner TJ. Exocytotic Ca2+ channels in mammalian central neurons. Trends Neurosci . 1995; 18: 89–98.
    OpenUrlCrossRefPubMed
  2. ↵
    Fletcher CF, Lutz CM, O’Sullivan TN, et al. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell . 1996; 87: 607–617.
    OpenUrlCrossRefPubMed
  3. ↵
    Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell . 1996; 87: 543–552.
    OpenUrlCrossRefPubMed
  4. ↵
    Sander T, Peters C, Janz D, et al. The gene encoding the alpha1A-voltage-dependent calcium channel (CACN1A4) is not a candidate for causing common subtypes of idiopathic generalized epilepsy. Epilepsy Res . 1998; 29: 115–122.
    OpenUrlCrossRefPubMed
  5. ↵
    Kruglyak L. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet . 1999; 22: 139–144.
    OpenUrlCrossRefPubMed
  6. ↵
    Boehnke M. A look at linkage disequilibrium. Nat Genet . 2000; 25: 246–247.
    OpenUrlCrossRefPubMed
  7. ↵
    Kendler KS, MacLean CJ, Ma Y, O’Neill FA, Walsh D, Straub RE. Marker-to-marker linkage disequilibrium on chromosomes 5q, 6p, and 8p in Irish high-density schizophrenia pedigrees. Am J Med Genet . 1999; 88: 29–33.
    OpenUrlCrossRefPubMed

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 99 (7)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise